Insulet Corporation (PODD) has expanded the commercial availability of its Omnipod 5 Automated Insulin Delivery system to the Middle East, including the UAE, Saudi Arabia, Qatar, and Kuwait. The company also introduced Omnipod Discover, a data management platform for diabetes care. Additionally, Insulet updated its supply agreement with NXP USA, Inc., effective January 1, 2026, to ensure continuity of component supply and revise commercial terms.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Insulet Corporation (PODD) Announces Strategic Expansion and Supply Agreement Update
Insulet Corporation (PODD) has expanded the commercial availability of its Omnipod 5 Automated Insulin Delivery system to the Middle East, including the UAE, Saudi Arabia, Qatar, and Kuwait. The company also introduced Omnipod Discover, a data management platform for diabetes care. Additionally, Insulet updated its supply agreement with NXP USA, Inc., effective January 1, 2026, to ensure continuity of component supply and revise commercial terms.